Literature DB >> 20541423

The 26S proteasome: assembly and function of a destructive machine.

Nerea Gallastegui1, Michael Groll.   

Abstract

The heart of the ubiquitin-mediated degradation pathway, the 26S proteasome, endoproteolytically cleaves most intracellular proteins, thereby maintaining biological homeostasis and regulating many crucial processes in the cell. This hydrolyzing machine comprises more than 30 different subunits, which perform different functions including the recognition, unfolding, translocating and cleavage of protein substrates. Thus, careful assemblage and regulation of the 26S proteasome is essential to ensure correct positioning and function of each subunit, thereby preserving the delicate cellular balance between protein synthesis and degradation. Here, we review the most current research on the 26S proteasome assembly pathway, and describe the mechanism used by the cell to manage the complex structure and functions of the proteasome.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2010        PMID: 20541423     DOI: 10.1016/j.tibs.2010.05.005

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  76 in total

1.  Silencing of SIAH1 in SH-SY5Y affects α-synuclein degradation pathway.

Authors:  Jing Xu; Xin-Zhi Zhang; Yong-Jin Zhang; Xiu-Ming Li; Zeng-Lin Cai; Xiao-Min Li
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

2.  Participation of proteasome-ubiquitin protein degradation in autophagy and the activation of AMP-activated protein kinase.

Authors:  Shaoning Jiang; Dae Won Park; Yong Gao; Saranya Ravi; Victor Darley-Usmar; Edward Abraham; Jaroslaw W Zmijewski
Journal:  Cell Signal       Date:  2015-02-26       Impact factor: 4.315

3.  A Bioinorganic Approach to Fragment-Based Drug Discovery Targeting Metalloenzymes.

Authors:  Seth M Cohen
Journal:  Acc Chem Res       Date:  2017-07-17       Impact factor: 22.384

4.  Discovery of an Inhibitor of the Proteasome Subunit Rpn11.

Authors:  Christian Perez; Jing Li; Francesco Parlati; Matthieu Rouffet; Yuyong Ma; Andrew L Mackinnon; Tsui-Fen Chou; Raymond J Deshaies; Seth M Cohen
Journal:  J Med Chem       Date:  2017-02-13       Impact factor: 7.446

Review 5.  The ubiquitin-proteasome system: opportunities for therapeutic intervention in solid tumors.

Authors:  Daniel E Johnson
Journal:  Endocr Relat Cancer       Date:  2014-03-21       Impact factor: 5.678

6.  SLUG-induced elevation of D1 cyclin in breast cancer cells through the inhibition of its ubiquitination.

Authors:  Mukul K Mittal; Kshipra Singh; Smita Misra; Gautam Chaudhuri
Journal:  J Biol Chem       Date:  2010-11-02       Impact factor: 5.157

7.  Potential usage of proteasome inhibitor bortezomib (Velcade, PS-341) in the treatment of metastatic melanoma: basic and clinical aspects.

Authors:  Mohammad A Shahshahan; Maureen N Beckley; Ali R Jazirehi
Journal:  Am J Cancer Res       Date:  2011-08-23       Impact factor: 6.166

8.  AAA ATPase p97/VCP is essential for TRIM21-mediated virus neutralization.

Authors:  Felix Hauler; Donna L Mallery; William A McEwan; Susanna R Bidgood; Leo C James
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

9.  One-shot NMR analysis of microbial secretions identifies highly potent proteasome inhibitor.

Authors:  Martin L Stein; Philipp Beck; Markus Kaiser; Robert Dudler; Christian F W Becker; Michael Groll
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

10.  The ubiquitin-proteasome system and the autophagic-lysosomal system in Alzheimer disease.

Authors:  Yasuo Ihara; Maho Morishima-Kawashima; Ralph Nixon
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.